NASDAQ : FTRE

Fortrea Holdings Inc. — News

$19.215 USD

-$0.3 (-1.56%)

Volume
813.63K
Average Volume
1.46M
Market Capitalization
$1.82B
P/E Ratio
-3.90
Dividend Yield
0.00%
Price Target
$18.00
Year High
$20.19
Year Low
$5.27
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.95
Source Headline
Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Fortrea Holdings Inc. (Nasdaq: FTRE) (“Fortrea”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/fortrea-holdings/ Recently a securities fraud complaint was filed against Fortrea on behalf of certain investors who purchased shares of the company's stock between July 5, 2023 and February 28, 2025 (the “Wrongdoing Period”). Accor.

businesswire.com - 2026-07-23 07:00:00

Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call

DURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026.

globenewswire.com - 2026-07-13 09:00:00

Stocks Look Shaky, But This Sector is Booming (Biotech)

Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.

zacks.com - 2026-07-09 14:06:06

FTRE or ARGX: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Fortrea Holdings Inc. (FTRE) and argenex SE (ARGX). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com - 2026-07-07 12:41:12

New Strong Buy Stocks for July 7th

DEC, FTRE, HG, PARR and KE have been added to the Zacks Rank #1 (Strong Buy) List on July 7, 2026.

zacks.com - 2026-07-07 06:45:12

Fortrea Names Jason Knoblauch as Chief Financial Officer

Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea

globenewswire.com - 2026-06-26 07:00:00

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the granting of an inducement award of restricted stock units (“RSUs”) on June 10, 2026, to 10 newly hired employees. The award consisted of 240,500 RSUs that vest in three equal annual installments starting June 10, 2027, subject to the employee's continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company's Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement material to the individual becoming a new employee of the Company.

globenewswire.com - 2026-06-10 16:15:00

Fortrea to Attend Jefferies Global Healthcare Conference

DURHAM, N. C. , June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization ("CRO"), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference: Jefferies Global Healthcare Conference (NYC)Date: Thursday, June 4, 2026Time: 8:45 AM EDTFormat: Fireside Chat To register for the live webcast, please click here.

globenewswire.com - 2026-06-02 18:00:55

Fortrea to Attend Jefferies Global Healthcare Conference

DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference:

globenewswire.com - 2026-06-02 18:00:00

Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript

Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-05 15:51:16

Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates

Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.02 per share a year ago.

zacks.com - 2026-05-05 08:27:12

Fortrea Reports First Quarter 2026 Results

Strong first-quarter performance reinforces confidence in FY 2026 guidance Book-to-bill of 1.15x is third consecutive quarter above 1.1x

globenewswire.com - 2026-05-05 06:00:00

Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?

Acadia (ACAD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-29 11:01:47

Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth

Fortrea Holdings Inc. (FTRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-28 11:08:34

Get FTRE Insider Trade Alerts

FTRE Price Target Summary

Last Month

$16.00

1 analysts

Last Quarter

$17.17

6 analysts

Last Year

$15.10

21 analysts

All Time

$18.40

31 analysts

FTRE Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-13 Mizuho Maintain Neutral Neutral
2026-06-24 Barclays Maintain Equal Weight Equal Weight
2026-05-12 Mizuho Maintain Neutral Neutral
2026-05-06 Citigroup Maintain Buy Buy
2026-05-06 Barclays Maintain Equal Weight Equal Weight
2026-04-14 Barclays Maintain Equal Weight Equal Weight
2026-04-08 Evercore ISI Group Maintain Outperform Outperform
2026-03-09 TD Cowen Upgrade Hold Buy
2026-02-27 Barclays Maintain Equal Weight Equal Weight
2026-02-27 Baird Maintain Outperform Outperform
2026-01-22 TD Cowen Maintain Hold Hold
2026-01-08 Truist Securities Upgrade Hold Buy
2026-01-06 Evercore ISI Group Upgrade In Line Outperform